Income Taxes
The source of pre-tax income and the components of income tax expense are as follows:
| | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
| (in millions) | 2025 | | 2024 | | 2023 |
| Income components: | | | | | |
| Domestic | $ | 695 | | | $ | 471 | | | $ | 123 | |
| Foreign | 486 | | | 616 | | | 512 | |
| Total pre-tax income | $ | 1,181 | | | $ | 1,087 | | | $ | 635 | |
| Income tax expense (income) components: | | | | | |
| Current: | | | | | |
| Domestic – federal | $ | 122 | | | $ | 108 | | | $ | (4) | |
| Domestic – state and local | 36 | | | 35 | | | 23 | |
| Foreign | 108 | | | 90 | | | 86 | |
| Total Current | $ | 266 | | | $ | 233 | | | $ | 105 | |
| Deferred: | | | | | |
| Domestic – federal | $ | (30) | | | $ | (38) | | | $ | (49) | |
| Domestic – state and local | (7) | | | (11) | | | (8) | |
| Foreign | 2 | | | 13 | | | (22) | |
| Total Deferred | (35) | | | (36) | | | (79) | |
| Total income tax provision | $ | (231) | | | $ | (197) | | | $ | (26) | |
| Effective income tax rate | 19.5 | % | | 18.1 | % | | 4.1 | % |
Reconciliations between taxes at the U.S. federal statutory tax rate and taxes at our effective income tax rate on earnings before income taxes are as follows:
| | | | | | | | | | | | | | | | |
| Year Ended December 31, | | | | | | |
| (in millions) | 2025 | | | | |
| U.S. federal statutory tax rate | $ | 248 | | 21.0 | % | | | | | | |
| State & local income tax, net of federal benefit (NOFB) | 21 | | 1.8 | % | (a) | | | | | |
| Foreign tax effects | | | | | | | | |
| Switzerland | | | | | | | | |
| Statutory tax rate difference between Switzerland and U.S. | (28) | | (2.4) | % | | | | | | |
| Effect of cantonal and communal income taxes | 9 | | 0.7 | % | | | | | | |
| | | | | | | | |
| | | | | | | | |
| Other adjustments | (3) | | (0.3) | % | | | | | | |
| Luxembourg | | | | | | | | |
| | | | | | | | |
| Changes in valuation allowances | 17 | | 1.5 | % | | | | | | |
Tax effect of internal reorganization | (18) | | (1.5) | % | | | | | | |
| | | | | | | | |
| Other adjustments | 3 | | 0.3 | % | | | | | | |
| Malta | | | | | | | | |
| Notional interest deduction | (19) | | (1.6) | % | | | | | | |
Notional interest carryforward | (36) | | (3.1) | % | | | | | | |
Changes in valuation allowances | 36 | | 3.1 | % | | | | | | |
| Other adjustments | 3 | | 0.2 | % | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| Other foreign jurisdictions | 26 | | 2.2 | % | | | | | | |
| | | | | | | | |
| Effect of cross-border tax laws | | | | | | | | |
| | | | | | | | |
| | | | | | | | |
Foreign exchange on repatriations | 13 | | 1.1 | % | | | | | | |
| Other adjustments | (5) | | (0.4) | % | | | | | | |
| Tax credits | (10) | | (0.9) | % | | | | | | |
| | | | | | | | |
| | | | | | | | |
| Changes in valuation allowances | 2 | | 0.2 | % | | | | | | |
| Nontaxable or nondeductible items | 4 | | 0.3 | % | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| Changes in unrecognized tax benefits | 4 | | 0.3 | % | | | | | | |
| Other adjustments | | | | | | | | |
Deferred tax effects of internal reorganization | (42) | | (3.6) | % | (b) | | | | | |
| Other adjustments | 6 | | 0.6 | % | | | | | | |
| Effective income tax rate | $ | 231 | | 19.5 | % | | | | | | |
(a) State and local taxes in California, Florida, Texas, Minnesota, New York, and Pennsylvania made up the majority (greater than 50 percent) of the tax effect in this category
(b) $42 million benefit reflects a one-time deferred tax benefit recorded in connection with an internal reorganization executed during the year.
| | | | | | | | | | | |
| Year Ended December 31, |
| 2024 | | 2023 |
| Tax provision at U.S. statutory rate | 21.0 | % | | 21.0 | % |
| Increase (decrease) in tax rate resulting from: | | | |
| State income taxes | 1.8 | | | 1.7 | |
| Uncertain tax positions | — | | | (9.9) | |
| U.S. tax on foreign earnings | 1.2 | | | 2.5 | |
| Tax incentives | (1.3) | | | (2.6) | |
| Valuation allowance | 1.7 | | | (5.8) | |
| Gain on remeasurement of previously held equity interest | (3.0) | | | — | |
| Rate change | (0.6) | | | (2.0) | |
| Federal R&D tax credit | (0.6) | | | (0.5) | |
| Stock compensation | (0.7) | | | (0.6) | |
| U.S. foreign derived intangible income tax benefit | (0.6) | | | (0.7) | |
| Tax on distribution of foreign earnings | 1.0 | | | — | |
| Non-deductible compensation | 0.4 | | | 1.2 | |
| Other tax credits | (0.2) | | | (1.8) | |
| Other – net | (2.0) | | | 1.6 | |
| Effective income tax rate | 18.1 | % | | 4.1 | % |
Income taxes paid (net of refunds) for the years ended December 31 are as follows:
| | | | | | | | | | | | | | | | | | | | |
| (in millions) | Year Ended December 31, | |
| Jurisdiction | 2025 | | 2024 | | 2023 | |
| Federal | $ | 135 | | | $ | 79 | | | $ | 114 | | |
| State & Local | 37 | | | 32 | | | 29 | | |
| Foreign | | | | | | |
| Netherlands | — | | (a) | 14 | | | — | | (a) |
| Switzerland | 14 | | 24 | | 11 | |
| United Kingdom | — | | (a) | 12 | | — | | (a) |
| All other foreign jurisdictions | 81 | | | 58 | | | 57 | | |
| Total Taxes Paid | $ | 267 | | | $ | 219 | | | $ | 211 | | |
(a) Amounts for these jurisdictions in 2025 and 2023 fall below the 5% threshold and are not required to be disclosed under ASU 2023-09.
Deferred tax assets and liabilities are determined based on temporary differences between the financial reporting and tax bases of assets and liabilities, applying enacted tax rates in effect for the year in which we expect the differences will reverse.
The following is a summary of the components of the net deferred tax assets and liabilities recognized in the Consolidated Balance Sheets:
| | | | | | | | | | | |
| December 31, |
| (in millions) | 2025 | | 2024 |
| Deferred tax assets: | | | |
| Employee benefits | $ | 58 | | | $ | 77 | |
| Accrued expenses | 49 | | | 52 | |
| Loss and other tax credit carryforwards | 333 | | | 236 | |
| R&D capitalization | 68 | | | 57 | |
| Inventory | 4 | | | 3 | |
| | | |
| Lease Liabilities | 95 | | | 73 | |
| | | |
| Hedging instruments | 77 | | | 2 | |
| Other | 31 | | | 11 | |
| Total deferred tax assets | 715 | | | 511 | |
| Valuation allowance | (290) | | | (189) | |
| Net deferred tax asset | $ | 425 | | | $ | 322 | |
| Deferred tax liabilities: | | | |
| Intangibles | $ | 482 | | | $ | 501 | |
| Investment in foreign subsidiaries | 10 | | | 6 | |
| Property, plant and equipment | 103 | | | 105 | |
| Lease right-of-use assets | 91 | | | 70 | |
| Hedging Instruments | 1 | | | 7 | |
| Other | 2 | | | 5 | |
| Total deferred tax liabilities | $ | 689 | | | $ | 694 | |
Management assesses all available positive and negative evidence, including prudent and feasible tax planning strategies, and estimates if sufficient future taxable income will be generated to realize existing deferred tax assets. On the basis of this evaluation, as of December 31, 2025, a valuation allowance of $290 million has been established to reduce the deferred income tax asset related to certain U.S. and foreign net operating losses and U.S. and foreign capital loss carryforwards.
A reconciliation of the change in valuation allowance on deferred tax assets is as follows:
| | | | | | | | | | | | | | | | | |
| (in millions) | 2025 | | 2024 | | 2023 |
| Valuation allowance — January 1 | $ | 189 | | | $ | 179 | | | $ | 204 | |
| Change in assessment (a) | (4) | | | — | | | (47) | |
| Current year operations | 57 | | | 22 | | | 12 | |
| Other comprehensive income | 3 | | | 1 | | | 1 | |
| Foreign currency and other (b) | 45 | | | (12) | | | 5 | |
| Acquisitions | — | | | (1) | | | 4 | |
| Valuation allowance — December 31 | $ | 290 | | | $ | 189 | | | $ | 179 | |
(a) Decrease in valuation allowance in 2025 and 2023 is primarily attributable to changes in realization on deferred tax assets in various foreign jurisdictions.
(b) Increase in 2025 and decrease in 2024 in valuation allowance is primarily attributed to foreign exchange movement impacting foreign balances.
Deferred taxes are classified in the Consolidated Balance Sheets as follows:
| | | | | | | | | | | |
| December 31, |
| (in millions) | 2025 | | 2024 |
| | | |
| Non-current assets | $ | 141 | | | $ | 125 | |
| | | |
| Non-current liabilities | (405) | | | (497) | |
| Total net deferred tax liabilities | $ | (264) | | | $ | (372) | |
Tax attributes available to reduce future taxable income begin to expire as follows:
| | | | | | | | | | | |
| (in millions) | December 31, 2025 | | First Year of Expiration |
| U.S. net operating loss | $ | 2 | | | December 31, 2026 |
| U.S. tax credits | 7 | | | December 31, 2032 |
| State net operating loss | 99 | | | December 31, 2026 |
| State excess interest expense | 26 | | | Indefinite |
| | | |
| Foreign net operating loss | 1,359 | | | December 31, 2026 |
| Foreign tax credits | 5 | | | December 31, 2030 |
Unrecognized Tax Benefits
We recognize tax benefits from uncertain tax positions only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities or upon the completion of the litigation process, based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such positions are measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate resolution.
A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:
| | | | | | | | | | | | | | | | | |
| (in millions) | 2025 | | 2024 | | 2023 |
| Unrecognized tax benefits — January 1 | $ | 37 | | | $ | 35 | | | $ | 102 | |
| Gross Increases - Current year tax positions | 6 | | | 3 | | | 2 | |
| Gross Increases - Prior year tax positions | 6 | | | 1 | | | 4 | |
| Gross Decreases - Prior year tax positions | (1) | | | (1) | | | (75) | |
| Acquisitions | — | | | 4 | | | 2 | |
| Settlements | — | | | (2) | | | — | |
| Lapse of Statute of Limitations | — | | | (3) | | | — | |
| Currency Translation Adjustment | 1 | | | — | | | — | |
| Unrecognized tax benefits — December 31 | $ | 49 | | | $ | 37 | | | $ | 35 | |
The amount of unrecognized tax benefits at December 31, 2025, which, if ultimately recognized, will reduce our effective tax rate, is $49 million. Changes in tax laws, regulations, administrative practices, principles, and interpretations may impact our unrecognized tax benefits. The timing of the resolution of income tax controversies is highly uncertain, and the amounts ultimately paid, if any, upon resolution of the issues raised by the taxing authorities may differ from the amounts accrued. It is reasonably possible that within the next twelve months we will receive additional assessments by various tax authorities or possibly reach resolution of income tax controversies in one or more jurisdictions. These assessments or settlements could result in changes to our unrecognized tax benefits related to positions on prior years’ tax filings. The actual amount of any change could vary significantly depending on the ultimate timing and nature of any settlements. We cannot currently provide an estimate of the range of possible outcomes.
We classify interest relating to unrecognized tax benefits as a component of other non-operating (expense) income, net and tax penalties as a component of income tax expense in our Consolidated Income Statements. The amount of accrued interest relating to unrecognized tax benefits as of December 31, 2025 and 2024 was $9 million and $7 million, respectively.
During 2019, Xylem’s Swedish subsidiary received a tax assessment from the Swedish Tax Agency (the "STA") for the 2013 tax year related to the tax treatment of an intercompany transfer of certain intellectual property that was made in connection with a reorganization of our European businesses. Xylem filed an appeal with the Administrative Court of Växjö, which rendered a decision adverse to Xylem in June 2022 for SEK837 million (approximately $91 million USD), consisting of the full tax assessment amount plus penalties and interest. Xylem has appealed this decision with the intermediate appellate court, the Administrative Court of Appeal, and on May 15, 2024, that court rendered a decision in favor of Xylem and also remanded an issue to the trial court for resolution. In December 2025, the trial court issued a ruling on the remanded issue in Xylem's favor. The STA has appealed this ruling to the Administrative Court of Appeal. Management, in consultation with external legal advisors, continues to believe it is more likely than not that Xylem will prevail on the proposed assessment and will continue to vigorously defend our position through this litigation. There can be no assurance that the final determination by the authorities will not be materially different than our position. As of December 31, 2025, we have not recorded any unrecognized tax benefits related to this uncertain tax position.
The following table summarizes our earliest open tax years by major jurisdiction:
| | | | | | | | |
| Jurisdiction | | Earliest Open Year |
| Italy | | 2020 |
| Luxembourg | | 2021 |
| Sweden | | 2013 |
| Germany | | 2016 |
| United Kingdom | | 2021 |
| United States | | 2017 |
| Switzerland | | 2019 |